Physician profile
Mathew Cholankeril
NPI 1588694780
$16,936.83
in general payments reported to CMS, 2019-2025
37 companies · $945 in 2025
The $945 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,354 · 2020: $7,749 · 2021: $2,115 · 2022: $2,012 · 2023: $1,296 · 2024: $1,466 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,706.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $6,775.98 | 2020 | |
| Abbott Laboratories | $2,782.72 | 2019-2025 | Aveir, Jot Dx, Gallant |
| Astrazeneca Pharmaceuticals LP | $2,233.09 | 2019-2025 | Farxiga, Breztri |
| Baxter Healthcare | $708.77 | 2022-2025 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $579.00 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $430.76 | 2019-2024 | Lifevest |
| Biotronik INC. | $411.25 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $323.39 | 2019-2024 | Verquvo |
| Novo Nordisk INC | $277.40 | 2019-2025 | Ozempic, Rybelsus |
| Shockwave Medical, INC | $255.83 | 2021-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $216.56 | 2023 | Lux-Dx Insertable Cardiac Monitor, Mylux Patient Kit With Mobile Device, Watchman Access System |
| Medtronic, INC. | $201.82 | 2022-2025 | Ffrangio, Onyx Frontier, Symplicity G3 |
| Vifor Pharma, INC. | $200.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $177.70 | 2020-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $171.78 | 2021-2024 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $145.14 | 2019-2024 | Xarelto |
| Abiomed | $120.50 | 2025 | |
| Amarin Pharma, INC. | $117.01 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $108.13 | 2019-2025 | Camzyos, Eliquis |
| Kowa Pharmaceuticals America, INC. | $102.16 | 2022 | |
| Pfizer INC. | $101.21 | 2019-2023 | |
| Scpharmaceuticals INC. | $66.94 | 2024-2025 | |
| Lexicon Pharmaceuticals, INC. | $55.40 | 2023 | Inpefa |
| Lilly USA, LLC | $40.36 | 2019-2020 | |
| Daiichi Sankyo INC. | $39.58 | 2019-2023 | Injectafer |
| Cordis US Corp. | $39.25 | 2022-2024 | Mynxgrip |
| Acist Medical Systems, INC. | $35.41 | 2025 | |
| Penumbra, INC. | $34.39 | 2021-2024 | Indigo System |
| Medtronic Vascular, INC. | $33.51 | 2019 | |
| Bardy Diagnostics, INC. | $30.00 | 2020 | |
| Amgen INC. | $28.62 | 2020-2021 | |
| Atricure, INC. | $24.36 | 2025 | Atriclip Laa Exclusion System |
| Edwards Lifesciences Corporation | $17.98 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Mannkind Corporation | $15.00 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $12.93 | 2021 | |
| Glaxosmithkline, LLC. | $12.90 | 2021 | |
| Althera Pharmaceuticals LLC | $10.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathew Cholankeril listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.